Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
Public ClinicalTrials.gov record NCT00095524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind Study on the Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
Study identification
- NCT ID
- NCT00095524
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Interventions
- Aripiprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2004
- Primary completion
- Jul 31, 2006
- Completion
- Jul 31, 2006
- Last update posted
- Nov 10, 2013
2004 – 2006
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Anaheim | California | — | — |
| Local Institution | Cerritos | California | — | — |
| Local Institution | Garden Grove | California | — | — |
| Local Institution | National City | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | New Britain | Connecticut | — | — |
| Local Institution | North Miami | Florida | — | — |
| Local Institution | Augusta | Georgia | — | — |
| Local Institution | Macon | Georgia | — | — |
| Local Institution | Hoffman Estates | Illinois | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Glen Burnie | Maryland | — | — |
| Local Institution | Haverhill | Massachusetts | — | — |
| Local Institution | Worcester | Massachusetts | — | — |
| Local Institution | Minneapolis | Minnesota | — | — |
| Local Institution | Brooklyn | New York | — | — |
| Local Institution | Nashville | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | DeSoto | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
| Local Institution | Wauwatosa | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00095524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00095524 live on ClinicalTrials.gov.